TRINITY BIOTECH PLC (TRIB) Net margin 2015–2024
TRINITY BIOTECH PLC (TRIB) net profit margin by fiscal year — reported net income divided by reported revenue.
-51.6%FY2024 · since FY2015: 21.8% → -51.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -51.6% | -9.4 pp |
| FY2023 | -42.3% | +23.3 pp |
| FY2022 | -65.6% | -66.7 pp |
| FY2021 | 1.1% | +7.3 pp |
| FY2020 | -6.3% | +25.7 pp |
| FY2019 | -32.0% | -9.2 pp |
| FY2018 | -22.8% | +17.9 pp |
| FY2017 | -40.6% | +60.4 pp |
| FY2016 | -101.0% | -122.8 pp |
| FY2015 | 21.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TRIB financial trends
TRIB RevenueTRIB Net incomeTRIB Gross profitTRIB Gross marginTRIB Operating incomeTRIB Operating marginTRIB Operating cash flowTRIB Free cash flowTRIB Capital expendituresTRIB Return on equityTRIB Stock buybacksTRIB Dividends paidTRIB Total assetsTRIB Total liabilitiesTRIB Shareholders’ equityTRIB overview →